Using Synthetic Biology to Reprogram the Cellular Aging Process in Yeast

Engineering a synthetic oscillator that cycles between the two deterioration pathways that lead to cell death can slow aging in yeast cells, increasing their longevity by more than 80%, a new study reports. The findings represent a proof-of-concept example of using synthetic biology to reprogram the cellular aging process. Given that the underlying aging pathways are conserved, the findings may one day enable the design of synthetic gene circuits that promote longevity in more complex organisms.

Cellular aging is a fundamental and complex biological process and is an underlying driver for many diseases. Although recent advances in synthetic biology have enabled the design of gene networks to control specific cellular functions, the ability to rationally engineer complex traits like cellular longevity remains elusive. Cellular aging in yeast (Saccharomyces cerevisiae) – a single-celled microorganism that has proven to be a genetically tractable model for the aging of mitotic cell types – is controlled by a genetic circuit that guides an aging cell to die in one of two ways: either rDNA instability or mitochondrial dysfunction.

Leveraging this mechanism, Zhen Zhou and colleagues controlled aging in yeast cells by manipulating the expression of two conserved transcriptional regulators: silent information regulator 2 (Sir2), which drives nucleolar decline, and heme activator protein 4 (Hap4), which is associated with mitochondrial biogenesis. The expression of Sir2 and Hap4 are linked in that expression of one cross-represses the other. The result is a naturally occurring and widely conserved transcriptional toggle-switch that drives cellular fate decisions.

Zhou et al. engineered a synthetic gene oscillator within yeast cells that re-wires this transcriptional toggle switch to generate sustained oscillations between the two states of cellular degeneration in individual cells. By creating a negative feedback loop in the Sir2-HAP circuit, the synthetic oscillator delays the commitment of yeast to one of the two cellular deterioration states. Zhou et al. found that cells containing the synthetic gene oscillator lived considerably longer – exhibiting an 82% increase in lifespan compared to that of wild type cells. In a related Perspective, Howard Salis discusses the study in greater detail. Reflecting on how the results may inform development of human therapeutics, he writes, "If the collective objective of these interven­tions is to maintain healthier cell states, then the risk and morbidity of age-associated dis­eases will be reduced."

Source:
Journal reference:

Zhou, Z., et al. (2023). Engineering longevity—design of a synthetic gene oscillator to slow cellular aging. Science. doi.org/10.1126/science.add7631.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of AZoLifeSciences.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Discovery of Novel Adrenal Cell Type Linked to Monogamy in Oldfield Mice